Atrial Fibrillation Detection and Management in Hypertension

被引:15
作者
Gawalko, Monika [1 ,2 ,3 ]
Linz, Dominik [2 ,3 ,4 ,5 ,6 ]
机构
[1] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland
[2] Maastricht Univ, Dept Cardiol, Med Ctr, NL-6202 AZ Maastricht, Netherlands
[3] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
[5] Univ Adelaide, Royal Adelaide Hosp, Ctr Heart Rhythm Disorders, Adelaide, Australia
[6] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands
关键词
atrial fibrillation; hypertension; primary prevention; secondary prevention; SYSTOLIC BLOOD-PRESSURE; RHYTHM CONTROL; RISK-FACTOR; CATHETER ABLATION; REDUCTION; BURDEN; METAANALYSIS; PREVENTION; RECURRENCE; SOCIETY;
D O I
10.1161/HYPERTENSIONAHA.122.19459
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is prevalent in >70% of atrial fibrillation patients. In turn, hypertensive patients have up to 73% greater likelihood of atrial fibrillation. Current guidelines recommend that a systematic atrial fibrillation screening may be justified in all patients aged >= 65 years with at least 1 cardiovascular disease, including hypertension. Although most blood pressure monitors include algorithms to detect atrial fibrillation with a high sensitivity of 96 [92-98]% and specificity of 94 [91-96]%, an electrocardiography confirmation is necessary to establish a diagnosis of atrial fibrillation. Early detection and diagnosis of atrial fibrillation is important to allow initiation of atrial fibrillation management. In the Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST-AFNET 4), hypertension was present in 88% of participants, and early rhythm control therapy lowered the risk of adverse cardiovascular outcomes in patients with early atrial fibrillation aged >75 or with CHA(2)DS(2)-VASc score >= 2 (Congestive heart failure, Hypertension, Age >= 75 (doubled), Diabetes, Stroke (doubled), Vascular disease, Age 65-74, Sex category [female]) and cardiovascular condition. Strategies for early atrial fibrillation detection should always be linked to a comprehensive atrial fibrillation work-up infrastructure organized within an integrated ABC pathway (Anticoagulation/Avoid stroke; Better symptom control; Cardiovascular and Comorbidity optimization). For secondary prophylaxis, blood pressure control should be embedded in a combined risk factor management program. In hypertensive patients where no atrial fibrillation is detected, intensive blood pressure lowering therapy for primary prophylaxis should be initiated to reduce the risk of developing atrial fibrillation and other cardiovascular complications in the future. The aim of the article is to review the current literature on atrial fibrillation detection and management in hypertensive patients.
引用
收藏
页码:523 / 533
页数:11
相关论文
共 64 条
  • [1] Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation A Randomized Clinical Trial
    Abed, Hany S.
    Wittert, Gary A.
    Leong, Darryl P.
    Shirazi, Masoumeh G.
    Bahrami, Bobak
    Middeldorp, Melissa E.
    Lorimer, Michelle F.
    Lau, Dennis H.
    Antic, Nicholas A.
    Brooks, Anthony G.
    Abhayaratna, Walter P.
    Kalman, Jonathan M.
    Sanders, Prashanthan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (19): : 2050 - 2060
  • [2] Renal sympathetic denervation improves clinical outcomes in patients undergoing catheter ablation for atrial fibrillation and history of hypertension: A meta-analysis
    Atti, Varunsiri
    Turagam, Mohit K.
    Garg, Jalaj
    Lakkireddy, Dhanunjaya
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (05) : 702 - 708
  • [3] Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
    Ball, Jocasta
    Carrington, Melinda J.
    McMurray, John J. V.
    Stewart, Simon
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 1807 - 1824
  • [4] 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary *
    Chao, Tze-Fan
    Joung, Boyoung
    Takahashi, Yoshihide
    Lim, Toon Wei
    Choi, Eue-Keun
    Chan, Yi-Hsin
    Guo, Yutao
    Sriratanasathavorn, Charn
    Oh, Seil
    Okumura, Ken
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2022, 122 (01) : 20 - 47
  • [5] Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial
    Chen, Lin Y.
    Bigger, J. Thomas
    Hickey, Kathleen T.
    Chen, Haiying
    Lopez-Jimenez, Carlos
    Banerji, Mary Ann
    Evans, Gregory
    Fleg, Jerome L.
    Papademetriou, Vasilios
    Thomas, Abraham
    Woo, Vincent
    Seaquist, Elizabeth R.
    Soliman, Elsayed Z.
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (11) : 1276 - 1282
  • [6] Association of clinic and ambulatory blood pressure with new-onset atrial fibrillation: A meta-analysis of observational studies
    Coccina, Francesca
    Pierdomenico, Anna M.
    De Rosa, Matteo
    Cuccurullo, Chiara
    Pierdomenico, Sante D.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (06) : 1104 - 1111
  • [7] Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials
    Emdin, Connor A.
    Callender, Tom
    Cao, Jun
    Rahimi, Kazem
    [J]. EUROPACE, 2015, 17 (05): : 701 - 710
  • [8] The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences
    Gawalko, Monika
    Duncker, David
    Manninger, Martin
    van der Velden, Rachel M. J.
    Hermans, Astrid N. L.
    Verhaert, Dominique V. M.
    Pison, Laurent
    Pisters, Ron
    Hemels, Martin
    Sultan, Arian
    Steven, Daniel
    Gupta, Dhiraj
    Heidbuchel, Hein
    Sohaib, Afzal
    Wijtvliet, Petra
    Tieleman, Robert
    Gruwez, Henri
    Chun, Julian
    Schmidt, Boris
    Keaney, John J.
    Mueller, Patrick
    Lodzinski, Piotr
    Svennberg, Emma
    Hoekstra, Olga
    Jansen, Ward P. J.
    Desteghe, Lien
    de Potter, Tom
    Tomlinson, David R.
    Neubeck, Lis
    Crijns, Harry J. G. M.
    Pluymaekers, Nikki A. H. A.
    Hendriks, Jeroen M.
    Linz, Dominik
    [J]. EUROPACE, 2021, 23 (07): : 1003 - 1015
  • [9] Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
    Guo, Yutao
    Lip, Gregory Y. H.
    [J]. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2020, 9 (01) : 5 - 7
  • [10] Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials
    Harskamp, Ralf E.
    Lucassen, Wim A. M.
    Lopes, Renato D.
    Himmelreich, Jelle C. L.
    Parati, Gianfranco
    van Weert, Henk C. P. M.
    [J]. ACTA CARDIOLOGICA, 2022, 77 (03) : 191 - 195